Invention Grant
- Patent Title: Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase
- Patent Title (中): 吡咯并[2,3-B]吡嗪可用作ATR激酶的抑制剂
-
Application No.: US13531461Application Date: 2012-06-22
-
Publication No.: US08822469B2Publication Date: 2014-09-02
- Inventor: Somhairle MacCormick , Pierre-Henri Storck , Michael Paul Mortimore , Jean-Damien Charrier , Ronald Knegtel , Stephen Clinton Young , Joanne Pinder , Steven John Durrant
- Applicant: Somhairle MacCormick , Pierre-Henri Storck , Michael Paul Mortimore , Jean-Damien Charrier , Ronald Knegtel , Stephen Clinton Young , Joanne Pinder , Steven John Durrant
- Applicant Address: US MA Boston
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Boston
- Agent Jennifer G. Che
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; C07D241/36
![Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase](/abs-image/US/2014/09/02/US08822469B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to pyrrolopyrazines compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.The compounds of this invention have formula I: wherein the variables are as defined herein.
Public/Granted literature
- US20130018035A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Public/Granted day:2013-01-17
Information query
IPC分类: